Blog
Notes from Latent.
Research, product notes and company news from the team building pharmacy intelligence.
5th Aug2026Latent Earns a 94.5 in the 2026 KLAS Emerging Company SpotlightCompanyKLAS scored Latent Health 94.5 overall, with A+ ratings for likelihood to recommend, partnership, and would buy again, in the first KLAS Spotlight report on enterprise pharmacy intelligence.Read 
1st July2026GLP-1 Bridge is Here. How Latent HelpsProductMedicare's GLP-1 Bridge could make millions more people eligible for medicines that used to run $1,000+/month, for about $50. What it means for pharmacy teams, and how we're helping our partners meet the wave.Read 
17th June2026Pushing the Pareto Frontier for Clinical DeidentificationResearchCIPHER is Latent's 1.5B-parameter de-identification model: frontier-level recall of 97.9% on PHI redaction at about 1/1000th the inference cost of frontier LLMs.Read 
18th Mar2026Latent Raises $80M to Close the Gap Between Diagnosis and TreatmentCompanyAn $80M Series A co-led by Spark Capital and Transformation Capital, with Conviction, McKesson Ventures, General Catalyst and Y Combinator. Why the work between a diagnosis and a filled prescription is where we build.Read 
14th May2025Adaptive LLMs for Medical Question Answering via EvolutionResearchHow we adapt language models to the expert, guideline-driven questions inside prior authorization while still using the newest model releases.Read